Purchases and Sales Made in Q1 2022 in Cyma Bay Therapeutics, Inc. (CBAY)
This table provides information about the institutional ownership of Cyma Bay Therapeutics, Inc. (CBAY) during Q1 2022. The information is specifically focused on institutions that hold shares of CymaBay Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-72.9K- 43.68% |
$202K - $265K
|
93.9K
$0
|
|
|
May 13, 2022
Q1 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-77.4KClosed |
$214K - $282K
|
0
$0
|
|
|
May 11, 2022
Q1 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-78.8K- 5.7% |
$218K - $287K
|
1.3M
$0
|
|
|
May 16, 2022
Q1 2022
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-95K- 5.31% |
$263K - $346K
|
1.69M
$0
|
|
|
May 13, 2022
Q1 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-106K- 5.31% |
$294K - $386K
|
1.89M
$0
|
|
|
May 11, 2022
Q1 2022
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-196KClosed |
$543K - $714K
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Stonepine Capital Management, LLC
Bend, OR |
SELL
|
- |
-300KClosed |
$831K - $1.09M
|
0
$0
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-339K- 73.13% |
$939K - $1.23M
|
125K
$0
|
|
|
May 16, 2022
Q1 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-681KClosed |
$1.89M - $2.48M
|
0
$0
|